.svg){kind=small}
Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Proof has demonstrated consistent performance in the California market across several product categories. In the Capsules category, Proof maintained a steady rank of 11th in October and November 2024, improving slightly to 10th in December 2024 and January 2025. This stability suggests a strong foothold in the Capsules segment, although the sales figures indicate some fluctuations. Meanwhile, in the Tincture & Sublingual category, Proof consistently held its position within the top 10, ranking 8th in October 2024 and maintaining 9th place in the subsequent months. This consistent ranking, coupled with a general upward trend in sales, points to a solid consumer base and effective product offerings in this category.
In contrast, Proof's performance in the Concentrates category reveals some challenges. While the brand did not make it into the top 30 throughout the months, its rank fluctuated from 68th in October 2024 to 63rd in November and January 2025, with a dip to 72nd in December 2024. This indicates a competitive landscape where Proof is striving to gain traction. However, the Topical category presents a more optimistic picture, with Proof improving its rank from 13th in October 2024 to 11th in January 2025, despite a dip in sales in November. This upward movement suggests that Proof is making strategic gains in the Topical market, which could be a key area of growth for the brand moving forward.
Competitive Landscape
In the competitive landscape of the California Tincture & Sublingual market, Proof has maintained a consistent rank of 9th from October 2024 through January 2025. Despite this steady position, Proof faces stiff competition from brands like ABX / AbsoluteXtracts and Jade Nectar, which have shown more dynamic rank changes and higher sales figures. ABX / AbsoluteXtracts improved its rank from 9th to 7th, with a noticeable sales increase, while Jade Nectar fluctuated between 7th and 8th but consistently outperformed Proof in sales. Meanwhile, St Ides entered the top 10 in November 2024 and maintained its position, indicating a growing presence. These trends suggest that while Proof holds a stable position, there is significant upward momentum among its competitors, which could impact Proof's market share if these trends continue.
Notable Products
In January 2025, Proof's top-performing product was the Indica Full Spectrum Oil Syringe (1g) in the Concentrates category, reclaiming its first-place position after a dip to third in December 2024, with sales reaching $774. The CBD/THC 1:1 Balance Tincture (300mg CBD, 300mg THC, 15ml) in the Tincture & Sublingual category followed closely, dropping from first place in December to second. The CBD:THC 1:1 Bazillion Tincture Drops (1000mg CBD, 1000mg THC, 15ml) maintained a consistent performance, ranking third for the fourth consecutive month. The THC Rich Tincture (2mg CBD, 900mg THC, 15ml) secured the fourth position, showing stability in its ranking since November 2024. Notably, the CBD Extra Strength Tincture (1000mg CBD, 15ml) made its debut in the rankings at fifth place, indicating a positive reception in the market.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
